These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results]. Haase D; Hanf V; Schulz T Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180 [TBL] [Abstract][Full Text] [Related]
24. Favorable early response of secondary chronic myeloid leukemia to imatinib. Waldman D; Weintraub M; Freeman A; Neumann Y; Rechavi G; Toren A Am J Hematol; 2004 Apr; 75(4):217-9. PubMed ID: 15054813 [TBL] [Abstract][Full Text] [Related]
25. Is There an Entity of Radiation-Induced Chronic Myeloid Leukemia? Report of a Case and Brief Review of the Literature. Miyoshi I; Mori M; Yamasaki I; Daibata M J Clin Exp Hematop; 2020; 60(1):24-25. PubMed ID: 32224562 [No Abstract] [Full Text] [Related]
26. Relationship of leukemia risk to radiation dose following cancer of the uterine corpus. Curtis RE; Boice JD; Stovall M; Bernstein L; Holowaty E; Karjalainen S; Langmark F; Nasca PC; Schwartz AG; Schymura MJ J Natl Cancer Inst; 1994 Sep; 86(17):1315-24. PubMed ID: 8064889 [TBL] [Abstract][Full Text] [Related]
27. Myeloid leukaemia following therapy for a first primary cancer. Nandakumar A; Davis S; Moolgavkar S; Witherspoon RP; Schwartz SM Br J Cancer; 1991 May; 63(5):782-8. PubMed ID: 2039704 [TBL] [Abstract][Full Text] [Related]
28. Pelvic radiotherapy and the risk of secondary leukemia and multiple myeloma. Wright JD; St Clair CM; Deutsch I; Burke WM; Gorrochurn P; Sun X; Herzog TJ Cancer; 2010 May; 116(10):2486-92. PubMed ID: 20209618 [TBL] [Abstract][Full Text] [Related]
29. Chronic Myeloid Leukemia as Secondary Malignancy Following the Treatment of Hodgkin Lymphoma: A Case Series. Millett R; Aggarwal A; Tabbara I; Nassereddine S Anticancer Res; 2019 Aug; 39(8):4333-4335. PubMed ID: 31366526 [TBL] [Abstract][Full Text] [Related]
30. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493 [TBL] [Abstract][Full Text] [Related]
31. Secondary chronic myelogenous leukemia: a diverse pathogenesis? Aguiar RC; Beitler B; Dorlhiac-Llacer PE; Chamone DA Acta Haematol; 1994; 92(2):101-3. PubMed ID: 7817701 [TBL] [Abstract][Full Text] [Related]
32. Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients. Ramanarayanan J; Dunford LM; Baer MR; Sait SN; Lawrence W; McCarthy PL Leuk Res; 2006 Jun; 30(6):701-5. PubMed ID: 16330096 [TBL] [Abstract][Full Text] [Related]
33. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine. Pavithran K; Doval DC Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020 [TBL] [Abstract][Full Text] [Related]
34. The incidence of secondary leukemias. Leone G; Mele L; Pulsoni A; Equitani F; Pagano L Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043 [TBL] [Abstract][Full Text] [Related]
35. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014. Teepen JC; Curtis RE; Dores GM; Berrington de Gonzalez A; van den Heuvel-Eibrink MM; Kremer LCM; Gilbert ES; van Leeuwen FE; Ronckers CM; Morton LM Leukemia; 2018 Dec; 32(12):2580-2589. PubMed ID: 29795414 [TBL] [Abstract][Full Text] [Related]
36. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. Li S; Ilaria RL; Million RP; Daley GQ; Van Etten RA J Exp Med; 1999 May; 189(9):1399-412. PubMed ID: 10224280 [TBL] [Abstract][Full Text] [Related]
37. The risk of chronic myeloid leukemia: can the dose-response curve be U-shaped? Radivoyevitch T; Kozubek S; Sachs RK Radiat Res; 2002 Jan; 157(1):106-9. PubMed ID: 11754648 [TBL] [Abstract][Full Text] [Related]